BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7525921)

  • 1. Estimation and correlation of drug water solubility with pharmacological parameters required for biological activity.
    Morelock MM; Choi LL; Bell GL; Wright JL
    J Pharm Sci; 1994 Jul; 83(7):948-52. PubMed ID: 7525921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increased throughput method for the determination of partition coefficients.
    Hitzel L; Watt AP; Locker KL
    Pharm Res; 2000 Nov; 17(11):1389-95. PubMed ID: 11205732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational approaches to determine drug solubility.
    Faller B; Ertl P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):533-45. PubMed ID: 17588703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrochemical determination of partition coefficients of drugs.
    Kontturi K; Murtomäki L
    J Pharm Sci; 1992 Oct; 81(10):970-5. PubMed ID: 1432622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
    Henchoz Y; Guillarme D; Rudaz S; Veuthey JL; Carrupt PA
    J Med Chem; 2008 Feb; 51(3):396-9. PubMed ID: 18189348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of solubility screening methods in drug discovery].
    Sugaya Y; Yoshiba T; Kajima T; Ishihama Y
    Yakugaku Zasshi; 2002 Mar; 122(3):237-46. PubMed ID: 11905048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior.
    Cappelletto E; Firrito C; Pizzato M; Rebuffi L; Scardi P
    Pharm Dev Technol; 2018 Dec; 23(10):1128-1135. PubMed ID: 29688125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between drug dissolution and polymer hydration: a study using texture analysis.
    Li H; Gu X
    Int J Pharm; 2007 Sep; 342(1-2):18-25. PubMed ID: 17548178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.
    Peltonen L; Strachan C
    Molecules; 2015 Dec; 20(12):22286-300. PubMed ID: 26703528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
    Kleberg K; Jacobsen J; Müllertz A
    J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Themed issue: improve dissolution, solubility and bioavailability of poorly soluble drugs.
    Perrie Y; Rades T
    J Pharm Pharmacol; 2010 Nov; 62(11):1517-8. PubMed ID: 21039536
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental and computational screening models for prediction of aqueous drug solubility.
    Bergström CA; Norinder U; Luthman K; Artursson P
    Pharm Res; 2002 Feb; 19(2):182-8. PubMed ID: 11885560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of the causes of cocrystal dissociation at high humidity.
    Eddleston MD; Thakuria R; Aldous BJ; Jones W
    J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
    Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
    Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Innovative processes for bio-pharmaceuticals and poorly water-soluble API".
    Müller-Goymann C; Kwade A
    Eur J Pharm Biopharm; 2018 May; 126():1. PubMed ID: 29474867
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.